The Phase I Study of Recombinant Human Nerve Growth Factor Injection
Clinical trial NCT04232332 · UNKNOWN
Trial details
- NCT number
- NCT04232332
- Sponsor
- Beijing Tongren Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-26
- Primary completion
- 2021-12-31
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.